갑상선암에서 PET의 이용 = PET Application in Thyroid Cancer

참고문헌 (Reference)

1 "[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels" 84 : 2291-2302, 1999

2 "Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma" 128 : 1067-1074, 2000

3 "Value of FDG　PET in papillary thyroid carcinoma with negative 131I whole-body scan" 40 : 986-992, 1999

4 "Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels" 179 : 457-461, 2000

5 "Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography" 130 : 941-946, 2001

6 "Radiation dose assessment for I-131 therapy of thyriod cancer using I-124 PET imaging" 2 : 41-46, 1999

7 "Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer" 85 : 1107-1113, 2000

8 "Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects" 88 : 4100-4104, 2003

9 "Positron emission tomography in thyroid cancer management" 37 : 169-174, 2002

10 "Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET" 29 : 231-236, 2002

11 "Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma" 41 : 1989-1895, 2001

12 "Implication of 2-18F-fluoro-2-deoxyglucose positron emission tomography in the follow-up Hurthle cell thyroid cancer" 12 : 155-161, 2002

13 "Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative I-131 scan" 42 : 71-76, 2001

14 "Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis:an immunohistochemical study" 12 : 747-754, 2002

15 "Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors" 39 : 453-459, 1998

16 "Fluorine-18- fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area" 133 : 294-299, 2003

17 "Fluorine-18- FDG and Iodine-131-iodide uptake in thyroid cancer" 37 : 1468-1472, 1996

18 "Fluorine-18 fluorodeoxygluose positron emission tomography in medullary thyroid cancer:results of a multicentre study" 28 : 1671-1676, 2001

19 "Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study" 26 : 1547-1552, 1999

20 "Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer" 24 : 1342-1348, 1997

21 "F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes" 23 : 94-103, 2001

22 "F-18-FDG PET/CT에서 갑상선의 국소적 섭취 증가 빈도와 지연부분영상을 이용한 감별진단능 분석" 37 (37): 88-, 2003

23 "Expression patterns on N-ras oncogene, glucose transporter-1 gene and thyroid specific genes in papillary thyroid carcinoma" 44 (44): 41-, 2003

24 "Evaluation of dosimetry of radioiodine therapy in benign malignant thyroid disorders by means of iodine-124 and PET" 29 : 760-767, 2002

25 "Diagnostic value of 18F-FDG PET in primary and metastatic thyroid cancer" 36 (36): 196-, 1995

26 "Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer" 86 : 3779-3786, 2001

27 "Determination of malignancy of thyroid nodules with positron emission tomography" 114 : 728-735, 1993

28 "Combined positron emission tomography/ computed tomography imaging of recurrent thyroid cancer" 128 : 178-184, 2003

29 "Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy" 42 : 1464-1469, 2001

30 "An evaluation of FDG-PET in detection and differentiation of thyroid tumors" 18 : 957-963, 1997

31 "18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma" 43 : 66-71, 2002